Osteoprotegerin/TNFRSF11B Polyklonaler Antikörper
Osteoprotegerin/TNFRSF11B Polyklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 11534-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
11534-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA Osteoprotegerin/TNFRSF11B und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | Osteoprotegerin/TNFRSF11B fusion protein Ag2139 |
| Vollständiger Name | tumor necrosis factor receptor superfamily, member 11b |
| Berechnetes Molekulargewicht | 401 aa, 46 kDa |
| Beobachtetes Molekulargewicht | 56 kDa |
| GenBank-Zugangsnummer | BC030155 |
| Gene symbol | TNFRSF11B |
| Gene ID (NCBI) | 4982 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Osteoprotegerin (OPG), also known as tumor necrosis factor receptor superfamily member 11B (TNFRSF11B) and osteoclastogenesis inhibitory factor (OCIF), belongs to the tumor necrosis factor (TNF) receptor superfamily. By binding to RANKL, OPG inhibits osteoclastic activity and promoting bone formationis. OPG plays a key role on cell survival by inhibiting TRAIL-induced apoptosis. OPG also is involved in vascular biology, fibrosis, immunity, EMT, and the apoptosis of cancer cells (PMID: 35523775).









